TRIZIVIR Side Effects

6012954-0 | Speech Disorder Developmental
on Jan 29, 2007 Male patient from UNITED STATES , child 4 years of age, was treated with Trizivir (View Usage). Patient experienced the following unwanted or unexpected effects: speech disorder developmental. Trizivir dosage: .

5993945-2 | Double Outlet Right Ventricle, Laboratory Test Abnormal, Live Birth, Skull Malformation, Ventricular Septal Defect
Patient was taking Trizivir (View Usage). Patient had the following side effects: double outlet right ventricle, laboratory test abnormal, live birth, skull malformation, ventricular septal defect on Dec 03, 2008 from UNITED STATES Additional patient health information: Male patient , weighting 8.82 lb, was diagnosed with hiv infection (What is hiv infection?) and. Trizivir dosage: 2tab Per Day. During the same period patient was treated with KALETRA (4tab Per Day) (View Kaletra Review and Kaletra Label ). Patient was hospitalized.

5989012-4 | Back Pain, Malaise, Nephrolithiasis, Rash
Adverse event was reported on Dec 02, 2008 by a Female patient taking Trizivir (View Usage) (Dosage: ) was diagnosed with hiv infection (What is hiv infection?) and. Location: UNITED KINGDOM , 52 years of age, weighting 100.1 lb, After Trizivir was administered, patient had the following side effects: back pain (What is back pain?), malaise, nephrolithiasis, rash (What is rash?). During the same period patient was treated with COMBIVIR (View Combivir Review and Combivir Label ), FOSAMPRENAVIR (1400mg Per Day) (View Fosamprenavir Review and Fosamprenavir Label ), REYATAZ (View Reyataz Review and Reyataz Label ), ATAZANAVIR SULFATE (View Atazanavir Sulfate Review and Atazanavir Sulfate Label ), FUROSEMIDE (40mg Per Day) (View Furosemide Review and Furosemide Label ), RITONAVIR (100mg Per Day) (View Ritonavir Review and Ritonavir Label ).

5978611-1 | Fatigue, Intentional Overdose, Suicide Attempt
on Dec 03, 2008 Male patient from GERMANY , 48 years of age, weighting 132.3 lb, was treated with Trizivir (View Usage). Patient experienced the following unwanted or unexpected effects: fatigue, intentional overdose, suicide attempt. Trizivir dosage: . During the same period patient was treated with ALCOHOL (View Alcohol Review and Alcohol Label ), IBUPROFEN TABLETS (3200mg Single Dose) (View Ibuprofen Tablets Review and Ibuprofen Tablets Label ), ZOPICLON (60mg Single Dose) (View Zopiclon Review and Zopiclon Label ).


5955066-4 | Hepatotoxicity, Nervous System Disorder
on Oct 31, 2008 Male patient from FRANCE , 49 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Trizivir (View Usage). Patient had the following side effects: hepatotoxicity, nervous system disorder. Trizivir dosage: . During the same period patient was treated with COMBIVIR (View Combivir Review and Combivir Label ), VIRAMUNE (View Viramune Review and Viramune Label ), SUSTIVA (View Sustiva Review and Sustiva Label ).

5953660-8 | Hepatotoxicity, Skin Disorder
Patient was taking Trizivir (View Usage). After Trizivir was administered, patient had the following side effects: hepatotoxicity, skin disorder on Oct 31, 2008 from FRANCE Additional patient health information: Female patient , 31 years of age, was diagnosed with hiv infection (What is hiv infection?) and. Trizivir dosage: . During the same period patient was treated with KIVEXA (View Kivexa Review and Kivexa Label ), NORVIR (View Norvir Review and Norvir Label ), REYATAZ (View Reyataz Review and Reyataz Label ), BACTRIM (View Bactrim Review and Bactrim Label ).

5953655-4 | Nervous System Disorder
Adverse event was reported on Oct 31, 2008 by a Female patient taking Trizivir (View Usage) (Dosage: ) was diagnosed with hiv infection (What is hiv infection?) and. Location: FRANCE , 47 years of age, Patient experienced the following unwanted or unexpected effects: nervous system disorder. During the same period patient was treated with COMBIVIR (View Combivir Review and Combivir Label ), SUSTIVA (View Sustiva Review and Sustiva Label ), VIRAMUNE (View Viramune Review and Viramune Label ), INVIRASE (View Invirase Review and Invirase Label ), NORVIR (View Norvir Review and Norvir Label ).

5953649-9 | Adverse Event, Gastrointestinal Disorder, Hepatotoxicity
on Oct 31, 2008 Female patient from FRANCE , 31 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Trizivir (View Usage). Patient had the following side effects: adverse event, gastrointestinal disorder, hepatotoxicity. Trizivir dosage: . During the same period patient was treated with COMBIVIR (View Combivir Review and Combivir Label ), TELZIR (View Telzir Review and Telzir Label ), NORVIR (View Norvir Review and Norvir Label ), INVIRASE (View Invirase Review and Invirase Label ), VIREAD (View Viread Review and Viread Label ), PENTACARINAT (View Pentacarinat Review and Pentacarinat Label ), HEPSERA (View Hepsera Review and Hepsera Label ).

5953642-6 | Dyslipidaemia, Hepatotoxicity
on Oct 31, 2008 Male patient from FRANCE , 57 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Trizivir (View Usage). After Trizivir was administered, patient had the following side effects: dyslipidaemia, hepatotoxicity. Trizivir dosage: . During the same period patient was treated with EPIVIR (View Epivir Review and Epivir Label ), SUSTIVA (View Sustiva Review and Sustiva Label ), VIDEX (View Videx Review and Videx Label ), VIRAMUNE (View Viramune Review and Viramune Label ).

5953640-2 | Mitochondrial Cytopathy, Myositis
Patient was taking Trizivir (View Usage). Patient experienced the following unwanted or unexpected effects: mitochondrial cytopathy, myositis (What is myositis?) on Oct 31, 2008 from FRANCE Additional patient health information: Male patient , 38 years of age, was diagnosed with hiv infection (What is hiv infection?) and. Trizivir dosage: .

5953638-4 | Gastrointestinal Disorder, Immune System Disorder
Adverse event was reported on Oct 31, 2008 by a Female patient taking Trizivir (View Usage) (Dosage: ) was diagnosed with hiv infection (What is hiv infection?) and. Location: FRANCE , 35 years of age, Patient had the following side effects: gastrointestinal disorder, immune system disorder. During the same period patient was treated with TELZIR (View Telzir Review and Telzir Label ), COMBIVIR (View Combivir Review and Combivir Label ), VIREAD (View Viread Review and Viread Label ), FUZEON (View Fuzeon Review and Fuzeon Label ), VIDEX (View Videx Review and Videx Label ), ZOVIRAX (View Zovirax Review and Zovirax Label ), ATAZANAVIR SULFATE (View Atazanavir Sulfate Review and Atazanavir Sulfate Label ).

5951830-6 | Nervous System Disorder
on Oct 31, 2008 Female patient from FRANCE , 41 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Trizivir (View Usage). After Trizivir was administered, patient had the following side effects: nervous system disorder. Trizivir dosage: . During the same period patient was treated with EPIVIR (View Epivir Review and Epivir Label ), SUSTIVA (View Sustiva Review and Sustiva Label ), ZERIT (View Zerit Review and Zerit Label ).

5951826-4 | Haematotoxicity
on Oct 31, 2008 Male patient from FRANCE , 36 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Trizivir (View Usage). Patient experienced the following unwanted or unexpected effects: haematotoxicity. Trizivir dosage: . During the same period patient was treated with KIVEXA (View Kivexa Review and Kivexa Label ), EPIVIR (View Epivir Review and Epivir Label ), NORVIR (View Norvir Review and Norvir Label ), REYATAZ (View Reyataz Review and Reyataz Label ), VIREAD (View Viread Review and Viread Label ).

5951804-5 | Myocardial Infarction
Patient was taking Trizivir (View Usage). Patient had the following side effects: myocardial infarction on Nov 07, 2008 from UNITED STATES Additional patient health information: Male patient , 50 years of age, . Trizivir dosage: 1tab Twice Per Day. Patient was hospitalized.

5946540-5 | Gastrointestinal Disorder, Hepatotoxicity
Adverse event was reported on Oct 31, 2008 by a Male patient taking Trizivir (View Usage) (Dosage: ) was diagnosed with hiv infection (What is hiv infection?) and. Location: FRANCE , 56 years of age, After Trizivir was administered, patient had the following side effects: gastrointestinal disorder, hepatotoxicity. During the same period patient was treated with EPIVIR (View Epivir Review and Epivir Label ), VIRAMUNE (View Viramune Review and Viramune Label ), VIREAD (View Viread Review and Viread Label ).

5945199-0 | Dyspepsia, Haematotoxicity, Immune System Disorder
on Oct 31, 2008 Female patient from FRANCE , 33 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Trizivir (View Usage). Patient experienced the following unwanted or unexpected effects: dyspepsia, haematotoxicity, immune system disorder. Trizivir dosage: . During the same period patient was treated with ZIAGEN (View Ziagen Review and Ziagen Label ), COMBIVIR (View Combivir Review and Combivir Label ).

5945187-4 | Mitochondrial Cytopathy, Myositis
on Oct 31, 2008 Male patient from FRANCE , 43 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Trizivir (View Usage). Patient had the following side effects: mitochondrial cytopathy, myositis (What is myositis?). Trizivir dosage: . During the same period patient was treated with KALETRA (View Kaletra Review and Kaletra Label ), VIREAD (View Viread Review and Viread Label ), TELZIR (View Telzir Review and Telzir Label ), NORVIR (View Norvir Review and Norvir Label ), BACTRIM (View Bactrim Review and Bactrim Label ).

5943220-7 | Hepatotoxicity, Liver Disorder
Patient was taking Trizivir (View Usage). After Trizivir was administered, patient had the following side effects: hepatotoxicity, liver disorder on Oct 31, 2008 from FRANCE Additional patient health information: Female patient , 49 years of age, was diagnosed with hiv infection (What is hiv infection?) and. Trizivir dosage: . During the same period patient was treated with VIREAD (View Viread Review and Viread Label ).

5937480-6 |
Adverse event was reported on Oct 20, 2008 by a Male patient taking Trizivir (View Usage) (Dosage: ) was diagnosed with hiv infection (What is hiv infection?) and. Location: FRANCE , 48 years of age, .

5937479-X | Liver Disorder
on Oct 20, 2008 Male patient from FRANCE , 47 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Trizivir (View Usage). Patient had the following side effects: liver disorder. Trizivir dosage: . During the same period patient was treated with WELLVONE (View Wellvone Review and Wellvone Label ), BACTRIM (View Bactrim Review and Bactrim Label ).

5935611-5 | Liver Disorder
on Oct 20, 2008 Male patient from FRANCE , 45 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Trizivir (View Usage). After Trizivir was administered, patient had the following side effects: liver disorder. Trizivir dosage: . During the same period patient was treated with BACTRIM (View Bactrim Review and Bactrim Label ), TRUVADA (View Truvada Review and Truvada Label ), SUSTIVA (View Sustiva Review and Sustiva Label ).

5935608-5 |
Patient was taking Trizivir (View Usage). on Oct 20, 2008 from FRANCE Additional patient health information: Female patient , 49 years of age, was diagnosed with hiv infection (What is hiv infection?) and. Trizivir dosage: .

5935606-1 | Liver Disorder
Adverse event was reported on Oct 20, 2008 by a Male patient taking Trizivir (View Usage) (Dosage: ) was diagnosed with hiv infection (What is hiv infection?) and. Location: FRANCE , 66 years of age, Patient had the following side effects: liver disorder. During the same period patient was treated with EPIVIR (View Epivir Review and Epivir Label ), ZIAGEN (View Ziagen Review and Ziagen Label ), VIDEX (View Videx Review and Videx Label ), KALETRA (View Kaletra Review and Kaletra Label ), BACTRIM (View Bactrim Review and Bactrim Label ), URSOLVAN (View Ursolvan Review and Ursolvan Label ).

5935600-0 | Myocardial Infarction
on Oct 20, 2008 Male patient from FRANCE , 35 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Trizivir (View Usage). After Trizivir was administered, patient had the following side effects: myocardial infarction. Trizivir dosage: . During the same period patient was treated with VIRAMUNE (View Viramune Review and Viramune Label ).

5934190-6 |
on Oct 20, 2008 Male patient from FRANCE , 54 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Trizivir (View Usage). . Trizivir dosage: . During the same period patient was treated with CRIXIVAN (View Crixivan Review and Crixivan Label ), KALETRA (View Kaletra Review and Kaletra Label ), VIREAD (View Viread Review and Viread Label ), BACTRIM (View Bactrim Review and Bactrim Label ).

5934188-8 |
Patient was taking Trizivir (View Usage). on Oct 20, 2008 from FRANCE Additional patient health information: Male patient , 48 years of age, was diagnosed with hiv infection (What is hiv infection?) and. Trizivir dosage: . During the same period patient was treated with VIREAD (View Viread Review and Viread Label ), KALETRA (View Kaletra Review and Kaletra Label ), INVIRASE (View Invirase Review and Invirase Label ), BACTRIM (View Bactrim Review and Bactrim Label ).

5934181-5 |
Adverse event was reported on Oct 20, 2008 by a Male patient taking Trizivir (View Usage) (Dosage: ) was diagnosed with hiv infection (What is hiv infection?) and. Location: FRANCE , 70 years of age, .

5917406-1 | Angina Pectoris, Coronary Angioplasty, Coronary Arterial Stent Insertion
on Oct 13, 2008 Male patient from ITALY , 56 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Trizivir (View Usage). Patient experienced the following unwanted or unexpected effects: angina pectoris, coronary angioplasty, coronary arterial stent insertion. Trizivir dosage: . During the same period patient was treated with GEMFIBROZIL (View Gemfibrozil Review and Gemfibrozil Label ). Patient was hospitalized.

5917403-6 | Angina Pectoris
on Oct 13, 2008 Male patient from ITALY , 56 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Trizivir (View Usage). Patient had the following side effects: angina pectoris. Trizivir dosage: 2g Per Day. During the same period patient was treated with GEMFIBROZIL (View Gemfibrozil Review and Gemfibrozil Label ). Patient was hospitalized.

5913865-9 | Abortion Spontaneous
Patient was taking Trizivir (View Usage). After Trizivir was administered, patient had the following side effects: abortion spontaneous on Oct 01, 2008 from UNITED STATES Additional patient health information: Female patient , 32 years of age, was diagnosed with hiv infection (What is hiv infection?) and. Trizivir dosage: . During the same period patient was treated with KALETRA (4tab Per Day) (View Kaletra Review and Kaletra Label ).

5907483-6 | Cardiac Failure, Circulatory Collapse, Congestive Cardiomyopathy, Hyperhidrosis, Nasopharyngitis, Pleural Effusion, Pyrexia
Adverse event was reported on Sep 29, 2008 by a Male patient taking Trizivir (View Usage) (Dosage: 1tab Twice Per Day) was diagnosed with hiv infection (What is hiv infection?) and. Location: GERMANY , 35 years of age, weighting 167.6 lb, Patient experienced the following unwanted or unexpected effects: cardiac failure, circulatory collapse, congestive cardiomyopathy, hyperhidrosis, nasopharyngitis, pleural effusion, pyrexia. During the same period patient was treated with VIREAD (1tab In The Morning) (View Viread Review and Viread Label ), COTRIM (1tab Three Times Per Week) (View Cotrim Review and Cotrim Label ). Patient was hospitalized and became disabled.

5883904-2 | Abdominal Pain, Abdominal Tenderness, Blood Pressure Immeasurable, Cardiac Disorder, Cardiac Failure, Cardiac Tamponade, Cardio-respiratory Arrest, Cardiogenic Shock
on Sep 11, 2008 Female patient from UNITED KINGDOM , 35 years of age, weighting 130.1 lb, was diagnosed with hiv infection (What is hiv infection?) and was treated with Trizivir (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), abdominal tenderness, blood pressure immeasurable, cardiac disorder, cardiac failure, cardiac tamponade, cardio-respiratory arrest, cardiogenic shock. Trizivir dosage: . During the same period patient was treated with KIVEXA (View Kivexa Review and Kivexa Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ). Patient was hospitalized.

5853951-5 | Pathogen Resistance
on Aug 18, 2008 Male patient from UNITED KINGDOM , 35 years of age, was treated with Trizivir (View Usage). After Trizivir was administered, patient had the following side effects: pathogen resistance. Trizivir dosage: .

5852606-0 | Double Outlet Right Ventricle, Laboratory Test Abnormal, Patent Ductus Arteriosus, Premature Baby, Transposition Of The Great Vessels, Ventricular Septal Defect
Patient was taking Trizivir (View Usage). Patient experienced the following unwanted or unexpected effects: double outlet right ventricle, laboratory test abnormal, patent ductus arteriosus, premature baby, transposition of the great vessels, ventricular septal defect on Aug 13, 2008 from UNITED STATES Additional patient health information: Male patient , weighting 3.97 lb, was diagnosed with hiv infection (What is hiv infection?) and. Trizivir dosage: 1500mg Per Day. During the same period patient was treated with KALETRA (2000mg Per Day) (View Kaletra Review and Kaletra Label ), SEROQUEL (View Seroquel Review and Seroquel Label ).

5821484-8 | Angina Pectoris, Coronary Angioplasty, Coronary Arterial Stent Insertion
Adverse event was reported on Jul 17, 2008 by a Male patient taking Trizivir (View Usage) (Dosage: ) was diagnosed with hiv infection (What is hiv infection?) and. Location: ITALY , 56 years of age, Patient had the following side effects: angina pectoris, coronary angioplasty, coronary arterial stent insertion. During the same period patient was treated with GEMFIBROZIL (View Gemfibrozil Review and Gemfibrozil Label ). Patient was hospitalized.

5817271-7 | Cleft Lip And Palate
on Jul 11, 2008 Female patient from UNITED STATES , weighting 6.83 lb, was treated with Trizivir (View Usage). After Trizivir was administered, patient had the following side effects: cleft lip and palate (What is cleft lip and palate?). Trizivir dosage: 750mg Per Day. During the same period patient was treated with ZIDOVUDINE (View Zidovudine Review and Zidovudine Label ).

5813644-7 | Double Outlet Right Ventricle, Laboratory Test Abnormal, Premature Baby, Transposition Of The Great Vessels, Ventricular Septal Defect
on Jul 09, 2008 Male patient from UNITED STATES , weighting 3.97 lb, was diagnosed with hiv infection (What is hiv infection?) and was treated with Trizivir (View Usage). Patient experienced the following unwanted or unexpected effects: double outlet right ventricle, laboratory test abnormal, premature baby, transposition of the great vessels, ventricular septal defect. Trizivir dosage: 1500mg Per Day. During the same period patient was treated with KALETRA (2000mg Per Day) (View Kaletra Review and Kaletra Label ).

5803279-4 | Acute Coronary Syndrome, Arteriosclerosis Coronary Artery
Patient was taking Trizivir (View Usage). Patient had the following side effects: acute coronary syndrome, arteriosclerosis coronary artery on Jul 07, 2008 from UNITED STATES Additional patient health information: Male patient , 46 years of age, was diagnosed with retroviral infection and. Trizivir dosage: 300mg Twice Per Day. During the same period patient was treated with LOPINAVIR AND RITONAVIR (4cap Per Day) (View Lopinavir And Ritonavir Review and Lopinavir And Ritonavir Label ).

5803278-2 | Acute Coronary Syndrome, Arteriosclerosis Coronary Artery
Adverse event was reported on Jul 07, 2008 by a Male patient taking Trizivir (View Usage) (Dosage: 300mg Twice Per Day) was diagnosed with hiv infection (What is hiv infection?) and. Location: UNITED STATES , 46 years of age, After Trizivir was administered, patient had the following side effects: acute coronary syndrome, arteriosclerosis coronary artery. During the same period patient was treated with KALETRA (View Kaletra Review and Kaletra Label ).

5801730-7 | Hypertension, Oedema Peripheral, Pre-eclampsia, Proteinuria, Swelling Face
on Jun 30, 2008 Female patient from BOTSWANA , 22 years of age, was diagnosed with antiviral prophylaxis and was treated with Trizivir (View Usage). Patient experienced the following unwanted or unexpected effects: hypertension, oedema peripheral, pre-eclampsia, proteinuria, swelling face. Trizivir dosage: 1tab Twice Per Day. During the same period patient was treated with METHYLDOPA (View Methyldopa Review and Methyldopa Label ), HYDRALAZINE HCL (View Hydralazine Hcl Review and Hydralazine Hcl Label ), MAGNESIUM SULFATE (View Magnesium Sulfate Review and Magnesium Sulfate Label ), NIFEDIPINE (View Nifedipine Review and Nifedipine Label ), CEFOTAXIME SODIUM (View Cefotaxime Sodium Review and Cefotaxime Sodium Label ), METRONIDAZOLE HCL (View Metronidazole Hcl Review and Metronidazole Hcl Label ), FERROUS SULFATE TAB (View Ferrous Sulfate Tab Review and Ferrous Sulfate Tab Label ), FOLATE (View Folate Review and Folate Label ).

5798218-9 | Cor Pulmonale Acute, Deep Vein Thrombosis, Fibrin D Dimer Increased, Pain In Extremity, Phlebitis, Pulmonary Embolism, Respiratory Distress, Thrombophlebitis
on Jun 26, 2008 Male patient from FRANCE , 45 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Trizivir (View Usage). Patient had the following side effects: cor pulmonale acute, deep vein thrombosis (What is deep vein thrombosis?), fibrin d dimer increased, pain in extremity, phlebitis, pulmonary embolism (What is pulmonary embolism?), respiratory distress, thrombophlebitis. Trizivir dosage: 1tab Twice Per Day. During the same period patient was treated with RETROVIR (1tab Twice Per Day) (View Retrovir Review and Retrovir Label ), TRUVADA (1tab Per Day) (View Truvada Review and Truvada Label ). Patient was hospitalized.

5796507-5 | Lipodystrophy Acquired
Patient was taking Trizivir (View Usage). After Trizivir was administered, patient had the following side effects: lipodystrophy acquired on Jun 24, 2008 from UNITED STATES Additional patient health information: Female patient , 21 years of age, weighting 140.9 lb, was diagnosed with hiv infection (What is hiv infection?) and. Trizivir dosage: . During the same period patient was treated with MARAVIROC (150mg Twice Per Day) (View Maraviroc Review and Maraviroc Label ), NORVIR (View Norvir Review and Norvir Label ), RALTEGRAVIR (View Raltegravir Review and Raltegravir Label ), TENOFOVIR (View Tenofovir Review and Tenofovir Label ), PREZISTA (View Prezista Review and Prezista Label ).

5776942-1 | Pre-eclampsia, Proteinuria
Adverse event was reported on Jun 12, 2008 by a Female patient taking Trizivir (View Usage) (Dosage: 1tab Twice Per Day) was diagnosed with antiviral prophylaxis and. Location: BOTSWANA , 22 years of age, weighting 117.9 lb, Patient experienced the following unwanted or unexpected effects: pre-eclampsia, proteinuria. During the same period patient was treated with METHYLDOPA (View Methyldopa Review and Methyldopa Label ), HYDRALAZINE HCL (View Hydralazine Hcl Review and Hydralazine Hcl Label ). Patient was hospitalized.

5775223-X | Angina Pectoris
on Jun 10, 2008 Male patient from ITALY , 56 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Trizivir (View Usage). Patient had the following side effects: angina pectoris. Trizivir dosage: 2g Per Day. During the same period patient was treated with GEMFIBROZIL (View Gemfibrozil Review and Gemfibrozil Label ). Patient was hospitalized.

5757480-9 | Furuncle
on May 14, 2008 Female patient from NETHERLANDS , 42 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Trizivir (View Usage). After Trizivir was administered, patient had the following side effects: furuncle. Trizivir dosage: 1550 Mg/daily. During the same period patient was treated with KALETRA (1000 Mg/daily) (View Kaletra Review and Kaletra Label ). Patient was hospitalized.

5752396-6 | Acute Coronary Syndrome, Arteriosclerosis Coronary Artery
Patient was taking Trizivir (View Usage). Patient experienced the following unwanted or unexpected effects: acute coronary syndrome, arteriosclerosis coronary artery on May 27, 2008 from UNITED STATES Additional patient health information: Male patient , 46 years of age, was diagnosed with retroviral infection and. Trizivir dosage: 300mg Twice Per Day. During the same period patient was treated with LOPINAVIR + RITONAVIR (4cap Per Day) (View Lopinavir + Ritonavir Review and Lopinavir + Ritonavir Label ).

5744137-3 | Cardiac Failure, Cardiomyopathy, Dilatation Ventricular, Dyspnoea, Dyspnoea Exertional, Mitral Valve Incompetence, Oedema Peripheral, Orthopnoea, Tricuspid Valve Incompetence
Adverse event was reported on May 14, 2008 by a Male patient taking Trizivir (View Usage) (Dosage: ) was diagnosed with viral infection (What is viral infection?) and. Location: SWEDEN , 57 years of age, Patient had the following side effects: cardiac failure, cardiomyopathy (What is cardiomyopathy?), dilatation ventricular, dyspnoea, dyspnoea exertional, mitral valve incompetence, oedema peripheral, orthopnoea, tricuspid valve incompetence. During the same period patient was treated with TRYPTIZOL (View Tryptizol Review and Tryptizol Label ), LOPERAMID (View Loperamid Review and Loperamid Label ), COMBIVIR (View Combivir Review and Combivir Label ), AZT (View Azt Review and Azt Label ). Patient was hospitalized.

5740605-9 | Cleft Lip And Palate
on May 08, 2008 Female patient from UNITED STATES , weighting 6.83 lb, was treated with Trizivir (View Usage). After Trizivir was administered, patient had the following side effects: cleft lip and palate (What is cleft lip and palate?). Trizivir dosage: 750mg Per Day.

5728762-1 | Abdominal Distension, Lipoatrophy, Lipodystrophy Acquired
on Apr 28, 2008 Female patient from FRANCE , 53 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Trizivir (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal distension, lipoatrophy, lipodystrophy acquired. Trizivir dosage: 2tab Per Day.

5725197-2 | Stillbirth
Patient was taking Trizivir (View Usage). Patient had the following side effects: stillbirth on Apr 28, 2008 from UNITED STATES Additional patient health information: Female patient , 35 years of age, was diagnosed with hiv infection (What is hiv infection?) and. Trizivir dosage: .